5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 134.13▼ | 134.46▼ | 134.61▼ | 138.50▼ | 139.61▼ |
MA10 | 134.28▼ | 134.70▼ | 136.02▼ | 139.44▼ | 140.80▼ |
MA20 | 134.32▼ | 136.31▼ | 137.97▼ | 140.49▼ | 127.96▲ |
MA50 | 134.67▼ | 138.30▼ | 139.84▼ | 139.08▼ | 122.59▲ |
MA100 | 136.08▼ | 139.91▼ | 139.54▼ | 127.10▲ | 138.37▼ |
MA200 | 137.87▼ | 139.84▼ | 141.30▼ | 120.78▲ | 123.17▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.154▼ | -0.427▼ | -0.793▼ | 1.191▲ |
RSI | 42.812▼ | 30.994▼ | 28.523▼ | 41.075▼ | 53.209▲ |
STOCH | 41.409 | 14.770▼ | 12.599▼ | 41.250 | 72.002 |
WILL %R | -71.171 | -94.139▼ | -95.537▼ | -97.281▼ | -37.942 |
CCI | -132.396▼ | -79.202 | -112.221▼ | -125.704▼ | 22.514 |
Tuesday, October 07, 2025 03:11 AM
Abstracts have been published in the Sept 2025 supplement of Neuromuscular Disorders here .
|
Monday, October 06, 2025 03:12 PM
Robust improvement demonstrated across diverse set of clinical measures - - Patient-reported outcomes support clinical meaningfulness of improvements in function and strength - - Meaningful ...
|
Friday, October 03, 2025 05:39 AM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the 30th Annual Congress of the World Muscle Society (WMS) 2025 Congress, taking ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
10/10/25 | 138.08 | 139.12 | 133.65 | 134.05 | 680,300 |
09/10/25 | 140.48 | 140.87 | 137.33 | 137.78 | 659,300 |
08/10/25 | 138.82 | 142.14 | 137.80 | 140.81 | 661,200 |
07/10/25 | 141.97 | 141.97 | 138.11 | 138.36 | 507,000 |
06/10/25 | 143.01 | 143.01 | 140.84 | 141.50 | 529,500 |
03/10/25 | 143.39 | 143.78 | 140.775 | 141.95 | 647,400 |
02/10/25 | 140.32 | 142.72 | 139.69 | 142.55 | 744,500 |
01/10/25 | 139.35 | 141.25 | 137.85 | 140.74 | 491,693 |
30/09/25 | 137.27 | 138.93 | 136.18 | 138.70 | 453,254 |
29/09/25 | 138.84 | 138.84 | 135.47 | 138.00 | 452,703 |
|
|
||||
|
|
||||
|
|